As of 2026-01-08, the EV/EBITDA ratio of Novocure Ltd (NVCR) is -12.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novocure's latest enterprise value is 2,057.81 mil USD. Novocure's TTM EBITDA according to its financial statements is -159.57 mil USD. Dividing these 2 quantities gives us the above Novocure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 16.2x | 12.0x |
| Forward P/E multiples | 18.6x - 27.7x | 21.6x |
| Fair Price | (30.42) - (27.11) | (27.91) |
| Upside | -311.1% - -288.1% | -293.7% |
| Date | EV/EBITDA |
| 2026-01-02 | -11.99 |
| 2025-12-31 | -11.86 |
| 2025-12-30 | -12.06 |
| 2025-12-29 | -12.10 |
| 2025-12-26 | -12.24 |
| 2025-12-24 | -12.21 |
| 2025-12-23 | -12.10 |
| 2025-12-22 | -12.21 |
| 2025-12-19 | -11.79 |
| 2025-12-18 | -11.60 |
| 2025-12-17 | -11.44 |
| 2025-12-16 | -11.86 |
| 2025-12-15 | -11.89 |
| 2025-12-12 | -12.13 |
| 2025-12-11 | -12.37 |
| 2025-12-10 | -12.06 |
| 2025-12-09 | -11.70 |
| 2025-12-08 | -11.25 |
| 2025-12-05 | -11.28 |
| 2025-12-04 | -11.04 |
| 2025-12-03 | -11.07 |
| 2025-12-02 | -10.45 |
| 2025-12-01 | -10.98 |
| 2025-11-28 | -11.77 |
| 2025-11-26 | -11.74 |
| 2025-11-25 | -11.65 |
| 2025-11-24 | -11.58 |
| 2025-11-21 | -11.17 |
| 2025-11-20 | -10.83 |
| 2025-11-19 | -10.82 |
| 2025-11-18 | -10.82 |
| 2025-11-17 | -10.69 |
| 2025-11-14 | -10.73 |
| 2025-11-13 | -10.77 |
| 2025-11-12 | -10.76 |
| 2025-11-11 | -11.11 |
| 2025-11-10 | -10.69 |
| 2025-11-07 | -10.45 |
| 2025-11-06 | -10.69 |
| 2025-11-05 | -10.93 |
| 2025-11-04 | -11.20 |
| 2025-11-03 | -11.37 |
| 2025-10-31 | -11.77 |
| 2025-10-30 | -11.78 |
| 2025-10-29 | -12.24 |
| 2025-10-28 | -12.17 |
| 2025-10-27 | -12.31 |
| 2025-10-24 | -12.43 |
| 2025-10-23 | -12.55 |
| 2025-10-22 | -12.51 |